GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asia Green Biotechnology Corp (XCNQ:ASIA) » Definitions » Price-to-Free-Cash-Flow

Asia Green Biotechnology (XCNQ:ASIA) Price-to-Free-Cash-Flow : N/A (As of Jun. 06, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Asia Green Biotechnology Price-to-Free-Cash-Flow?

As of today (2024-06-06), Asia Green Biotechnology's share price is C$0.015. Asia Green Biotechnology's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.00. Hence, Asia Green Biotechnology's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Asia Green Biotechnology's Price-to-Free-Cash-Flow or its related term are showing as below:

XCNQ:ASIA's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.885
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Asia Green Biotechnology's Free Cash Flow per Share for the three months ended in Dec. 2023 was C$0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$-0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 64.80% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 26.50% per year.

During the past 6 years, Asia Green Biotechnology's highest 3-Year average Free Cash Flow per Share Growth Rate was 64.80% per year. The lowest was -91.30% per year. And the median was 53.10% per year.


Asia Green Biotechnology Price-to-Free-Cash-Flow Historical Data

The historical data trend for Asia Green Biotechnology's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asia Green Biotechnology Price-to-Free-Cash-Flow Chart

Asia Green Biotechnology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Asia Green Biotechnology Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Asia Green Biotechnology's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Asia Green Biotechnology's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asia Green Biotechnology's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asia Green Biotechnology's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Asia Green Biotechnology's Price-to-Free-Cash-Flow falls into.



Asia Green Biotechnology Price-to-Free-Cash-Flow Calculation

Asia Green Biotechnology's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.015/-0.001
=N/A

Asia Green Biotechnology's Share Price of today is C$0.015.
Asia Green Biotechnology's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Asia Green Biotechnology  (XCNQ:ASIA) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Asia Green Biotechnology Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Asia Green Biotechnology's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Asia Green Biotechnology (XCNQ:ASIA) Business Description

Traded in Other Exchanges
N/A
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.
Executives
Johannes Kingma Senior Officer

Asia Green Biotechnology (XCNQ:ASIA) Headlines